Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ceftiofur
2. Ceftiofur Hydrochloride
3. Naxcel
4. U 64279a
5. U-64279e
1. 104010-37-9
2. Ceftiofur Sodium Salt
3. Ceftiofur Monosodium Salt
4. Sodium Ceftiofur
5. Naxcel
6. Ceftiofur Sodium [usan]
7. Ceftiofur (sodium)
8. U-64279e
9. Ccris 7601
10. Ceftiofur Natrium
11. Cm 31-916
12. Nhi34is56e
13. Chebi:31383
14. Ceftiofurum
15. Cm-31-916
16. Sodium;(6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
17. Unii-nhi34is56e
18. Ceftiofur Sodium (tn)
19. Sodium (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(mercaptomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(z)-(o-methyloxime), 2-furoate (ester)
20. Ceftiofur Sodium (jan/usan)
21. Ceftiofur Sodium [jan]
22. Schembl2369906
23. Chembl2105998
24. Ceftiofur Sodium [mart.]
25. Dtxsid30891706
26. Ceftiofur Natrium [who-dd]
27. Hy-b0898
28. Mfcd01766184
29. Ceftiofur Sodium [green Book]
30. Akos015998604
31. Ceftiofur Monosodium Salt [mi]
32. Ks-1164
33. Ceftiofur Sodium [usp Monograph]
34. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((2-furanylcarbonyl)thio)methyl)-8-oxo-, Monosodium Salt, (6r-(6alpha,7beta(z)))-
35. D01682
36. (6r,7r)-7-[[(2z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
37. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((2-furanylcarbonyl)thio)methyl)-8-oxo-, Monosodium Salt, (6r-(6.alpha.,7.beta.(z)))-
38. Sodium (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(mercaptomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 72-(z)-(o-methyloxime), 2-furoate (ester)
39. Sodium (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Weight | 545.6 g/mol |
---|---|
Molecular Formula | C19H16N5NaO7S3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 9 |
Exact Mass | 545.01095567 g/mol |
Monoisotopic Mass | 545.01095567 g/mol |
Topological Polar Surface Area | 259 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 952 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
* Pigs:
- Treatment of bacterial respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis.
- Treatment of septicaemia, polyarthritis or polyserositis associated with Streptococcus suis infection.
* Cattle:
- Treatment of acute interdigital necrobacillosis in cattle also known as Panaritium or foot rot.
- Treatment of acute post-partum (puerperal) metritis in cattle, in cases where treatment with another antimicrobial has failed.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
QJ01DD90
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ceftiofur Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceftiofur Sodium, including repackagers and relabelers. The FDA regulates Ceftiofur Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceftiofur Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ceftiofur Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ceftiofur Sodium supplier is an individual or a company that provides Ceftiofur Sodium active pharmaceutical ingredient (API) or Ceftiofur Sodium finished formulations upon request. The Ceftiofur Sodium suppliers may include Ceftiofur Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Ceftiofur Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ceftiofur Sodium written confirmation (Ceftiofur Sodium WC) is an official document issued by a regulatory agency to a Ceftiofur Sodium manufacturer, verifying that the manufacturing facility of a Ceftiofur Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ceftiofur Sodium APIs or Ceftiofur Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Ceftiofur Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Ceftiofur Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ceftiofur Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ceftiofur Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ceftiofur Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ceftiofur Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ceftiofur Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ceftiofur Sodium suppliers with NDC on PharmaCompass.
Ceftiofur Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ceftiofur Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ceftiofur Sodium GMP manufacturer or Ceftiofur Sodium GMP API supplier for your needs.
A Ceftiofur Sodium CoA (Certificate of Analysis) is a formal document that attests to Ceftiofur Sodium's compliance with Ceftiofur Sodium specifications and serves as a tool for batch-level quality control.
Ceftiofur Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Ceftiofur Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ceftiofur Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceftiofur Sodium EP), Ceftiofur Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceftiofur Sodium USP).
LOOKING FOR A SUPPLIER?